Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

Pfizer’s decision to halt further marketing of Beqvez is further sign of the sparse patient interest in gene therapies for the bleeding condition.

Ixinity (trenonacog alfa) can effectively prevent and controlled bleeds in young children with severe or moderately severe ...

Columnist Jennifer Lynne stresses the significance of hidden symptoms in the lives of those with bleeding disorders.

Bin Liu, PhD, associate professor at The Hormel Institute, University of Minnesota, is among the authors of a newly published ...